Long-term therapy with paricalcitol for secondary hyperparathyroidism in hemodialysis patients

International Journal of Artificial Organs

Volumn 26, Issue 6, 2003, Pages 484-490

  Barton Pai, A ^a   Lin, S ^a   Arruda, J A L ^b   Lau, Alan H ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Calcium hemodialysis; Paricalcitol; Phosphorus; Secondary hyperparathyroidism; Vitamin D analogs

Indexed keywords

BODY FLUIDS; CALCIUM; DRUG DOSAGE; HEMODIALYZERS; PHOSPHORUS; VITAMINS;

CALCIUM CONCENTRATION; CALCIUM-HEMODIALYSIS; HAEMODIALYSIS; HYPERPARATHYROIDISM; PARATHYROID HORMONES; PARICALCITOL; PHOSPHORUS CONCENTRATION; SECONDARY HYPERPARATHYROIDISM; VITAMIN D ANALOG; VITAMIN-D;

DIALYSIS;

CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE BINDING AGENT; PHOSPHORUS;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HEMODIALYSIS; HORMONE INHIBITION; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; KIDNEY FAILURE; LONG TERM CARE; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM;

EID: 0042666835     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880302600606     Document Type: Article

References (13)

1. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, Macdonald PN, Brown AJ. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97: 2534-40.
2. Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats: The effects of calcium, phosphate and vitamin D. J Clin Invest 1995; 96: 1786-93.
3. Almaden Y, Canalejo A, Hernandez A, Ballesteros E, Garcia-Navarro S, Torres A, Rodriguez M. Direct effect of phosphorus on parathyroid hormone secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 1996; 11: 970-6.
4. Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med 1995; 333: 166-74.
5. Fournier A, Moriniere P, Sebert JL, Dkhissi H, Atik A, Leflon P, Renaud H, Gueris J, Gregoire I, Idrissi A. Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia. Kidney Int 186; 18 (suppl): S114-9.
6. 2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats. Am J Kidney Dis 1998; 32 (suppl 2): S40-7.
7. 2, supresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. Am J Kidney Dis 1997; 30: 105-12.
8. 2. Am J Kidney Dis 1998; 32 (suppl 2): S48-54.
9. 2. Am J Kidney Dis 1998; 32 (suppl 2): S61-6.
10. Payne RB, Carver ME, Morgan DB. Interpretation of serum total calcium: Effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol 1979; 32: 56-60.
11. Llach F, Yudd M. Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism. Am J Kidney Dis 2001; 38 (suppl 5): S45-50.
12. Slatopolsky E, Dusso A, Brown A. The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure. Am J Med Sci 1999; 317: 370-6.
13. Llach F, Yudd M. The importance of hyperphosphatemia in the severity of hyperparathyroidism and its treatment in patients with chronic renal failure. Nephrol Dial Transplant 1998; 13 (suppl 3): S57-61.